Abstract
Purpose. It is hypothesized that Epstein-Barr virus (EBV) has already infected the noncarcinomatous gastric mucosa before carcinogenesis of EBV-associated gastric carcinoma. However, the frequency and distribution of EBV infection in the gastric mucosa of chronic atrophic gastritis (CAG) are still unclear. To clarify these points, we evaluated the EBV DNA load in gastric mucosa with CAG.
Methods. We tested samples from 35 CAG cases. Paired biopsy specimens from five sites of the stomach were obtained according to the Updated Sydney System. One of each pair of specimens was subjected to a real-time quantitative polymerase chain reaction (Q-PCR) assay to detect EBV. Q-PCR was performed using the LightCycler System (Roche, Mannheim, Germany). The other was subjected to hematoxylin and eosin (H&E) and Giemsa staining. The histological degree of CAG was graded according to the Updated Sydney System. To evaluate the surface distribution of gastric mucosal atrophic changes of CAG, we modified the endoscopic classification of Kimura and Takemoto.
Result. EBV DNA was detected in 65.7% (23 of 35 cases) of the gastric biopsy specimens of the cases examined. EBV DNA was detected most frequently (92.3%; 12 of 13 cases) in the cases with endoscopically moderate CAG (p<0.01). There was a significant association between EBV detection and the presence of inflammatory cell infiltration and atrophy in the stomach with endoscopically moderate CAG.
Conclusion. EBV mainly infects the gastric mucosa of patients with moderate CAG.
Similar content being viewed by others
References
Miller G. Epstein-Barr virus; biology, pathogenesis, and medical aspect, in Virology, 2nd ed. (Fields BN, Knipl DN, eds.) New York: Raven Press, 1990, pp. 1921–1958.
Niedobitek G. The Epstein-Barr virus: a group 1 carcinogen? Virchows Arch 1999;435:79–86.
Rickinson AB, Kieff E. Epstein-Barr virus, in Virology, 3rd ed. (Fields BN, Knipl DN, Hawley PM, eds.) Philadelphia: Lipincott-Raven, 1996, pp. 2397–2446.
Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1964;1:702–703.
zur Hausen H, Schulte-Holthausen H, Klein G, et al. EBV-DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 1970;228:1056–1058.
Dickens P, Srivastava G, Loke SL, et al. Epstein-Barr virus DNA in nasopharyngeal carcinoma from Chinese patients in Hong Kong. J Clin Pathol 1992;45:396–397.
Shimizu N, Tanabe-Tochikura A, Kuroiwa Y, et al. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt’s lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J Virol 1994;68:6069–6073.
Takada K, Shimizu N, Tanabe-Tochikura A, et al. Pathogenic role of Epstein-Barr virus in human cancer. Intervirology 1995;38:214–220.
Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995;333:32–41.
Burke AP, Yen TS, Shekitka KM, et al. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol 1990;3:377–380.
Shibata D, Tokunaga M, Uemura Y, et al. Association of Epstein-Barr virus with undifferentiated gastric carcinoma with intense lymphoid infiltration. Lymphoepitheliomalike carcinoma. Am J Pathol 1991;139:469–474.
Tokunaga M, Land CE, Uemura Y, et al. Epstein-Barr virus in gastric carcinoma. Am J Pathol 1993;143:1250–1254.
Fukayama M, Hayashi Y, Iwasaki Y, et al. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab Invest 1994;71:73–81.
Imai S, Koizumi S, Sugihara M, et al. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 1994;91:9131–9135.
Rowlands DC, Ito M, Mangham DC, et al. Epstein-Barr virus and carcinomas: rare association of the virus with gastric carcinomas. Br J Cancer 1993;68:1014–1019.
Shibata D, Weiss LM. Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 1992;140:769–774.
Pittaluga S, Loke SL, So KC, et al. Clonal Epstein-Barr virus in lymphoepithelioma-like carcinoma of the stomach: demonstration of viral genome by in situ hybridization and Southern blot analysis. Mod Pathol 1992;5:661–664.
Nishikawa J, Imai S, Oda T, et al. Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression. J Virol 1999;73:1286–1292.
Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965;64:31–49.
Morson BC. Carcinoma arising from area of intestinal metaplasia in the gastric mucosa. Br J Cancer 1955;9:377–385.
Watanabe H, Enjoji M, Imai T. Gastric carcinoma with lymphoid stroma. Cancer 1976;38:232–243.
Yanai H, Murakami T, Yoshiyama H, et al. Epstein-Barr virus-associated gastric carcinoma and atrophic gastritis. J Clin Gastroenterol 1999;29:39–41.
Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969;1:87–97.
Yanai H, Takada K, Shimizu N, et al. Epstein-Barr virus infection in non-carcinomatous gastric epithelium. J Pathol 1997;183:293–298.
Heid CA, Stevens J, Livak KJ, et al. Real time quantitative PCR. Genome Res 1996;6:986–994.
Williams SJ, Schwer C, Krishnarao AS, et al. Quantitative competitative polymerase chain reaction: analysis of amplified products of the HIV-1 gag gene by capillary electrophoresis with laser-induced fluorescence detection. Anal Biochem 1996;236:146–152.
Baldanti F, Grossi P, Furione M, et al. High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J Clin Microbiol 2000;38:613–619.
Kimura H, Morita M, Yabuta Y, et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999;37:132–136.
Lo YM, Chan LY, Lo KW, et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 1999;59:1188–1191.
Lo YM, Leung SF, Chan LY, et al. Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma. Cancer Res 2000;60:2351–2355.
Lo YM, Chan YS, Chan AT, et al. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res 1999;59:5452–5455.
Lo YM, Chang WY, Ng EK, et al. Circulating Epstein-Barr virus DNA in the serum of patients with gastric carcinoma. Clin Cancer Res 2001;7:1856–1859.
Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161–1181.
Fujita S. Biology of early gastric carcinoma. Path Res Pract 1978;163:297–309.
Nonoyama M, Tanaka A. Plasmid DNA as a possible state of Epstein-Barr virus genomes in nonproductive cells. Cold Spring Harb Symp Quant Biol 1975;39:807–810.
Nonoyama M, Pagano JS. Detection of Epstein-Barr viral genome in non-productive cells. Nat New Biol 1971;233:103–106.
Nonoyama M, Pagano JS. Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-producing cells. Nat New Biol 1972;238:169–171.
Shotelersuk K, Khorprasert C, Sakdikul S, et al. Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer. Clin Cancer Res 2000;6:1046–1051.
Kaizaki Y, Sakurai S, Chong JM, et al. Atrophic gastritis, Epstein-Barr virus infection, and Epstein-Barr virus-associated gastric carcinoma. Gastric Cancer 1999;2:101–108.
Gilligan K, Rajadural P, Resnick L, et al. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc Natl Acad Sci USA 1990;87:8790–8794.
Yanai H, Nishikawa J, Mizugaki Y, et al. Endoscopic and pathologic features of Epstein-Barr virus-associated gastric carcinoma. Gastrointest Endosc 1997;39:236–242.
Yoshiyama H, Imai S, Shimizu N, et al. Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new receptor different from CD21. J Virol 1997;71:5688–5691.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hirano, A., Yanai, H., Shimizu, N. et al. Evaluation of Epstein-Barr virus DNA load in gastric mucosa with chronic atrophic gastritis using a real-time quantitative PCR assay. Int J Gastrointest Canc 34, 87–94 (2003). https://doi.org/10.1385/IJGC:34:2-3:087
Issue Date:
DOI: https://doi.org/10.1385/IJGC:34:2-3:087